Intratumor Injection of Thermosensitive Polypeptide with Resveratrol Inhibits Glioblastoma Growth
- 1 March 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Tissue Engineering, Part C: Methods
- Vol. 29 (3), 103-109
- https://doi.org/10.1089/ten.tec.2022.0207
Abstract
Local tumor treatment is a feasible measure for patients with glioblastoma (GBM) who are unsuitable for surgical resection. Interferon-elastin-like polypeptide (IFN-ELP(V)) is a slow-release, biodegradable, thermosensitive fusion protein with antitumor immunity, and resveratrol (Res) is a polyphenolic compound with an antitumor effect. In this study, we found that intratumor injection of IFN-ELP(V) combined with intraperitoneal injection of Res is more effective in delaying GBM growth in mice. Specifically, in an orthotopic GBM model, we found a significant improvement in the median survival with this strategy. Our results suggested that the combined use of IFN-ELP(V) and Res has a dramatic synergistic effect on GBM, thus providing a novel and effective therapeutic strategy for tumors.Keywords
This publication has 20 references indexed in Scilit:
- Advances in drug delivery technology for the treatment of glioblastoma multiformeJournal of Controlled Release, 2020
- Thermoresponsive and Protease‐Cleavable Interferon‐Polypeptide Conjugates with Spatiotemporally Programmed Two‐Step Release Kinetics for Tumor TherapyAdvanced Science, 2019
- Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent SignalingBioMed Research International, 2019
- One-month zero-order sustained release and tumor eradication after a single subcutaneous injection of interferon alpha fused with a body-temperature-responsive polypeptideBiomaterials Science, 2018
- Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathwayJournal of Cellular Physiology, 2018
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143Neuro-Oncology, 2017
- In Vitro and In Vivo Preclinical Effects of Type I IFNs on GliomasJournal of Interferon & Cytokine Research, 2017
- Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiationOncology Reports, 2015
- Prospects of immune checkpoint modulators in the treatment of glioblastomaNature Reviews Neurology, 2015
- Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic ImplicationsNeurotherapeutics, 2015